Transgene Market Cap

Transgene has a market cap or net worth of €248.09 million as of January 30, 2026. Its market cap has increased by 173.99% in one year.

Market Cap

248.09M

Enterprise Value

262.38M

Revenue

7.58M

Ranking

n/a

PE Ratio

n/a

Stock Price

€0.90

Market Cap Chart

Since March 30, 1998, Transgene's market cap has increased from 151.86M to 248.09M, an increase of 63.37%. That is a compound annual growth rate of 1.78%.

Market Cap History

Date	Market Cap	% Change
Jan 30, 2026	248.09M	-5.63%
Dec 31, 2025	262.87M	192.89%
Dec 31, 2024	89.75M	-34.86%
Dec 29, 2023	137.78M	-16.38%
Dec 30, 2022	164.76M	-33.52%
Dec 31, 2021	247.84M	79.73%
Dec 31, 2020	Upgrade Pro	Upgrade Pro
Dec 31, 2019	Upgrade Pro	Upgrade Pro
Dec 31, 2018	Upgrade Pro	Upgrade Pro
Dec 29, 2017	Upgrade Pro	Upgrade Pro
Dec 30, 2016	Upgrade Pro	Upgrade Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Novabase S.G.P.S.	350.97M
SIMONA Aktiengesellschaft	300.00M
EUWAX Aktiengesellschaft	267.80M
centrotherm international AG	232.79M
STINAG Stuttgart Invest AG	232.23M
Sino AG	229.08M
ÜSTRA Hannoversche Verkehrsbetriebe Aktiengesellschaft	208.56M
Allane SE	204.05M

Market Cap Rankings